Company Data
Castle Biosciences Inc.
Ticker
CSTL
Current Price
$27.32 -1.05%
Market Cap
$765.2M
Price Target
Refer to Report
Volume
352.5K
52wk Range
$16.965 - $35.84
Overview
Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others.